HMC reports its Q1 fiscal 2027 results on August 5 against a quietly shifting backdrop: the stock has recovered sharply but short sellers have been adding positions, while options traders remain unusually relaxed.
The most notable positioning development is in short interest, which has risen 27% over the past week to roughly 2.4 million shares — a move that stands out against the broader calm in the lending market. Despite the increase, borrowing HMC remains almost frictionless: cost to borrow has fallen more than 20% over the week to just 0.30%, and availability is wide at around 456% of shares already borrowed, meaning there are more than four and a half times as many shares available to lend as are currently out on loan. The borrow market, in other words, has not tightened to match the pickup in short demand — the shorts building here are doing so cheaply and easily.
Options positioning tells a different story from the growing short interest. The put/call ratio has drifted below its 20-day average to 0.99, roughly half a standard deviation below the mean, and well clear of the defensive readings — above 1.20 — that dominated through late June. That's a meaningful rotation: a month ago, put buyers were clearly in control; now the options market is more balanced. The price move reinforces the sentiment shift. HMC has climbed 11% over the past month to $30.11, recovering from a period of pressure. A modest 2% dip on the final session of July suggests some profit-taking ahead of the announcement rather than fresh concern.
Recent earnings reactions have been strongly positive. The May 2026 print delivered a 7.4% one-day gain and a further 7.8% over the following week, while the late June event added 4.4% on the day and 13.4% over five sessions. That pattern reflects genuine positive surprise capacity, consistent with Honda's Q1 operating profit of ¥716 billion — which beat expectations and led management to raise full-year guidance. Bulls are focused on accelerating EV sales and cost discipline as the electrification strategy gains traction. The stock's ORTEX growth score has been transformed by a dramatic improvement in its five-year EBIT trajectory, which flipped from deeply negative to strongly positive earlier this year. Formal analyst coverage on the US-listed ADR is thin and largely stale — the most recent meaningful change was a Macquarie downgrade to Neutral in June 2025, and most other actions are years old — so the Street debate is difficult to map cleanly here.
The August 5 print will test whether Honda can sustain the operating momentum that drove the recent upgrades and guidance lift, or whether the quietly accumulating short positions reflect a view that the stock's 11% monthly recovery has run ahead of what the numbers can support.
See the live data behind this article on ORTEX.
Open HMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
